Sacral Neuromodulation for Fecal Incontinence and Constipation: Evidence, Programming and Long-term Management Sakralnervmodulation in der Therapie der Stuhlinkontinenz und Obstipation: Evidenz, Programmierung und Langzeitmanagement

Bittorf B, Matzel K (2023)


Publication Type: Journal article, Review article

Publication year: 2023

Journal

Book Volume: 148

Pages Range: 228-236

Journal Issue: 3

DOI: 10.1055/a-2063-3630

Abstract

Background Over the last two decades, sacral neuromodulation (SNM) has established its role in the treatment of functional pelvic organ-/pelvic floor disorders. Even though the mode of action is not fully understood, SNM has become the preferred surgical treatment of fecal incontinence. Methods and Results A literature search was carried out on programming sacral neuromodulation and long-term outcomes in treating fecal incontinence and constipation. Sacral neuromodulation was found to be successful in the long term. Over the years, the spectrum of indications has expanded, and now includes patients presenting with anal sphincter lesions. The use of SNM for low anterior resection syndrome (LARS) is currently under clinical investigation. Findings of SNM for constipation are less convincing. In several randomised crossover studies, no success was demonstrated, even though it is possible that subgroups may benefit from the treatment. Currently the application cannot be recommended in general. The pulse generator programming sets the electrode configuration, amplitude, pulse frequency and pulse width. Usually pulse frequency and pulse width follow a default setting (14 Hz, 210 s), while electrode configuration and stimulation amplitude are adjusted individually to the patient need and perception of stimulation. Despite low infection rates and few electrode-/pulse generator dysfunctions, up to 65% of patients require surgical reintervention during long term follow-up - in 50% of cases because of battery depletion, which is an expected event. At least one reprogramming is necessary in about 75% of the patients during the course of the treatment, mostly because of changes in effectiveness, but rarely because of pain. Regular follow-up visits appear to be advisable. Conclusion Sacral neuromodulation can be considered to be a safe and effective long-term therapy of fecal incontinence. To optimise the therapeutic effect, a structured follow-up regime is advisable.

Authors with CRIS profile

How to cite

APA:

Bittorf, B., & Matzel, K. (2023). Sacral Neuromodulation for Fecal Incontinence and Constipation: Evidence, Programming and Long-term Management Sakralnervmodulation in der Therapie der Stuhlinkontinenz und Obstipation: Evidenz, Programmierung und Langzeitmanagement. Zentralblatt für Chirurgie, 148(3), 228-236. https://doi.org/10.1055/a-2063-3630

MLA:

Bittorf, Birgit, and Klaus Matzel. "Sacral Neuromodulation for Fecal Incontinence and Constipation: Evidence, Programming and Long-term Management Sakralnervmodulation in der Therapie der Stuhlinkontinenz und Obstipation: Evidenz, Programmierung und Langzeitmanagement." Zentralblatt für Chirurgie 148.3 (2023): 228-236.

BibTeX: Download